Introduction
The detailed molecular mechanisms by which nylate cyclase. However, the extent to which changes in cardiac responses to catecholamines result from changes in ,-adrenergic receptors or postreceptor components is not well known.
For example, previous studies have indicated that longterm treadmill running of pigs results in diminished maximal heart rates during exercise and isoproterenol stimulation and a down-regulation of right atrial /3-adrenergic receptors (1) . In the current studies we have extended these observations and find that, in spite of this down-regulation of p-receptors, the dose of isoproterenol yielding a 50% maximal heart rate response, the ED50, is decreased after training. Because this result suggested an increased efficiency of signal transduction despite down-regulation of receptor number, we asked whether the paradoxical findings of decreased receptor number and decreased ED50 might be explained by changes in the amount of Gs. We hypothesized that in the heart the amount of Gs might influence physiological responsiveness to catecholamines independently of changes in f3-adrenergic receptors. To quantitate the amount of Gs, we used a recently de- scribed ELISA assay that uses an anti-peptide antibody directed against a unique sequence in the as subunit of Gs (2) .
Methods
Animals. Five sexually mature Yucatan miniswine (Sus Scrofa; three males, two females) weighing 26±5 kg, were studied before and after chronic dynamic exercise. Thoracotomy was performed to obtain biopsies of the left ventricle and right atrium. Venous catheters were placed for pharmacological testing. After recovery from surgery animals underwent pharmacological and exercise testing to determine heart rate response, maximal work rate, and maximal oxygen consumption. Details of surgical procedures and physiological responses to exercise have been reported previously (1) . When exercise and pharmacological tests were complete animals underwent 7-9 wk of treadmill running (60 min/d, 5 d/wk, 9% grade, 100 m/min) and physiological and pharmacological tests were repeated. Finally, animals underwent terminal thoracotomy (initial surgical conditions were duplicated) and samples of the right atrium and left ventricle were obtained. Tissue was excised in the region of the initial biopsy sites, excluding scar tissue. Samples were cleansed ofblood and immediately frozen (-70'C). Pharmacological testing and exercise bouts were completed 72-96 h before terminal thoracotomy.
Testing ofchronotropic responsiveness. After recovery from surgery all animals underwent pharmacological testing using (-)isoproterenol. Tests were conducted in early morning hours in a quiet, dark laboratory (21°C). Response to isoproterenol was assessed by graded, bolus injection of (-)isoproterenol (0.01-2.0 ag/kg i.v.), and heart rate response was recorded until there was no further increase (usually 30 s). The 6-s period showing the largest increase in heart rate was defined as the maximal response. The heart rate was allowed to return to baseline between each dose of (-)isoproterenol. Injections were given until there was a < 5% increase in heart rate; the preceding dose was chosen as the one that caused a maximal response. The relation between change in heart rate and the logarithm of the dose of (-)isoproterenol was examined by linear regression analysis. Two or three tests conducted on separate days were combined into a single linear regression in the control and trained state in each animal. The dose of isoproterenol yielding ED50 was calculated from the linear regression equation.
To control for possible training-associated changes in reflex withdrawal of vagal tone occurring in response to isoproterenol-induced vasodilatation, isoproterenol dose-response tests were repeated after the administration of atropine sulfate (0.075 mg/kg i.v., bolus, with an additional 0.5 mg i.v., each 5 min for duration of test). f3-Adrenergic receptor binding studies. f3-Adrenergic receptors were identified using the radioligand ['25I]iodocyanopindolol in saturation isotherm experiments conducted on crude myocardial membrane preparations as previously described (1).
Quantitation of Gs. Quantitation of Gs was performed using an ELISA based on an antipeptide antibody generated to the as portion of Gs as previously described (2) . Myocardial biopsy samples were available from four animals. In all, 11 different samples were examined: 5 from the atria and 6 from the ventricle, 5 before and 6 after chronic exercise. For preparation of membranes, frozen tissue was powdered and then homogenized in glass-glass homogenizing tubes (Kontes Co., Vineland, NJ). An extraction to remove contractile protein, modified from Baker et al. (3), was performed. The membrane homogenate was diluted with 5 vol ofbuffer (Tris, EGTA, pH 7.5), an equal vol of 1.0 M KCl was added, and samples were incubated at 4VC for 20 min and then centrifuged (48,000 g for 20 min). The pellet was then suspended in buffer at a concentration of about 2.0 mg/ml. Protein concentration was determined by the method of Lowry (4) using BSA as standard.
The ELISA assay was conducted using supernatant fractions prepared from sodium cholate-extracted membranes. Membranes were extracted with 1% sodium cholate in 20 mM Tris-HCl (pH 8.0), 25 mM NaCl, and 1 mM EDTA (TEN) for 1 h on ice. The extract was centrifuged in a microfuge at 43,000 g for 1 h at 4°C and the supernatant fraction was diluted with 4 vol of TEN buffer containing TWEEN-20 so that the final TWEEN-20 concentration was 1%. Extracts were incubated with a 1:2,000 dilution ofthe Gs antibody for 1 h and then applied to a peptide-coated microtiter plate (2) . In studies conducted to validate this antibody, immunoblot experiments indicated that only as and not a subunits from other G proteins (at, ao) were detected by the antibody (2) . Immunoblot experiments with cardiac membrane preparation confirmed the detection of a 45-kD/52-kD protein, presumably as (data not shown), as previously reported for other cell types (2) .
Data analysis. Data are expressed as mean± 1 SD. Specific measurements made before and after training were compared using t testing for paired data. The null hypothesis was rejected when P < 0.05 (two-tailed). The Pearson product-moment correlation coefficient (r) is reported as a measure of the strength of association between change in heart rate and logarithm of the dose of(-)isoproterenol determined by linear regression analysis.
Results
Characterization ofthe model. We substantiated that the exercise protocol produced a training effect by measuring maximal systemic oxygen consumption, heart rate, and work rate before and after the training period. These data, which have been previously reported (1), showed a 25% increase in maximal oxygen consumption, a 29-beat/min decrease in basal heart rate, and a 100% increase in maximal work rate. Thus, animals subjected to this protocol showed substantial improvement in measures of cardiovascular performance. Isoproterenol-stimulated chronotropic response. Figs. 1 and 2 show results ofdose-response studies examining the ability of graded, bolus doses ofintravenous (-)isoproterenol to increase heart rate. In all five animals, after training, less isoproterenol was required to yield a 50% maximal heart rate response (0.07±0.03 vs. 0.03±0.01 ,ug/kg; P < 0.02). Mean correlation coefficients (r = 0.95±0.04) for the linear regressions relating logarithm ofthe (-)isoproterenol dose with heart rate response establish that the relationship is linear. Tests were repeated after administration of atropine sulfate to control for possible changes in reflex activation. Again, in all five animals, after training, less isoproterenol was required to yield a 50% maximal heart rate response (0.06±0.03 vs. 0.03±0.02 ttg/kg; P < 0.05). The maximal changes in isoproterenol-stimulated heart rate responses (i.e., maximal-basal) did not differ before and after the training period (119±9 vs. 109±27; P = NS). However, in these animals we observed an 18% decrease in isoproterenol-stimulated maximal heart rate and a 9% decrease in heart rate at maximal exercise after the training period (1). f3-Adrenergic receptor binding studies. As (Fig. 3) .
Quantitation of Gs. The amount of Gs was substantially increased in right atrial and left ventricular membranes after the training period (Fig. 4) . The mean increase in right atrial membranes was 42% (11.4±0.8 vs. 16.2±2.0 pmol/mg; P < 0.05), while in left ventricular membranes the mean increase was 76% (15.6±2.6 vs. 27.4±5.2 pmol/mg; P = 0.02).
Discussion
The key findings of this work are that a normal physiological perturbation, chronic dynamic exercise, is associated with changes in the amount of Gs protein in cardiac membranes, and that (-receptor number and Gs are not coordinately regulated in the heart.
The disparity between (-adrenergic receptor number and physiological responsiveness, as defined by the ED50 for isoproterenol-stimulated heart rate, suggests that the level of Gs in cardiac membranes is a critical determinant ofphysiological responsiveness to catecholamines. Exercise training appears to be associated with a more efficient transduction mechanism resulting in an enhanced response to (3-adrenergic stimulation by a reduced number of (3-adrenergic receptors. Thus, in the setting of increased amounts of Gs, reduction in receptor number may be adequately compensated so that physiological responsiveness is maintained or even increased.
Although it is commonly observed that changes in (3-adrenergic receptor number correlate with changes in responsiveness of the heart to catecholamines (5-7), discordancy between receptor number and physiological responsiveness has been described in several physiological and pathophysiological circumstances. For example, using treadmill running in rats, Takeda and colleagues described a down-regulation ofleft ventricular (-receptors but an increased responsiveness in papillary isometric responsiveness to catecholamine stimulation (8) . Similarly, Crampes and colleagues (9) found that adipocytes from trained humans exhibit enhanced lipolysis in response to catecholamine stimulation despite no change in adipocyte (3-receptor number. Our finding of noncoordinate regulation of (-receptor number and Gs provides a possible mechanism that may apply to other hormone-and neurotransmitter-stimulated systems in which receptor number and physiological responsiveness are discordant. For example, Longabaugh and co-workers reported myocardial (-receptor up-regulation but a decrease in adenylate cyclase activity in a canine model of pressure-overload hypertrophy with heart failure (10) . Using cholera toxin those investigators measured a 59% reduction in Gs levels in myocardial membranes from these dogs (10) . These data from a pathological state confirm our own data from a physiological setting, that levels of Gs may provide a key mechanism to account for changes in adrenergic responsiveness.
It is noteworthy that the cholera toxin-catalyzed ADP-ribosylation assay used by Longabaugh and colleagues (10) to quantitate membrane-associated Gs yielded 7.1±0.1 pmol Gs per mg canine ventricular membrane protein, a value -50% lower than what we find with the ELISA technique (15.6±2.6 pmol/mg). These differences may be due to the assays used, since our assay measures the amount ofthe protein itself rather than the contribution of other biochemical factors (endogenous ADP ribosylation, NADase, accessibility of substrates and cofactors), but a species difference is also possible.
Since chronic dynamic exercise is known to result in mild myocardial hypertrophy, it is possible that increased levels of Gs may be the result ofchanges in membrane yield rather than the reflection of a primary change in Gs itself. However, the ratios of heart weight to body weight, the best assessment for myocardial hypertrophy, were not increased during the training period (1) . Moreover, the left ventricle, which experiences the greatest stimulus for hypertrophy, showed no change in (3-adrenergic receptor number during the study, but showed a substantial increase in the amount of Gs. On the other hand, the atrium, which is less likely to experience substantial hypertrophy, showed decreases in (3-adrenergic receptor number and increases in the amounts ofGs. Taken with the physiological data, these data suggest a primary physiologically induced increase in Gs.
We previously reported that training-induced right atrial (3-adrenergic receptor down-regulation was associated with decreased isoproterenol-stimulated maximal heart rate and a reduction in the slope of the line relating logarithm of isoproterenol dose and change in heart rate (1). The current findings of decreased ED50 for isoproterenol-stimulated heart rate, which implies increased responsivity, suggests that slope, maximal response, and ED50 may reflect different features of receptormediated responses. In the current study and in another study of triiodothyronine-induced hyperthyroidism in pigs (1 1) we find that quantities of Gs and the ED50 for isoproterenol-stimulated heart rate are inversely related, and that right atrial (-adrenergic receptor number is directly related to isoproterenol-stimulated maximal heart rate and the slope of the doseresponse relationship. Current work in our laboratory is directed toward elucidating the relationships between receptor number, Gs, and physiological measures of responsivity in vivo.
The observation that the amount of Gs is not a static entity but can be changed by physiological perturbations is intriguing because it implies a potentially important means to regulate cardiac responsiveness to catecholamines and presumably other neurotransmitters and hormones. It should prove interesting to determine whether other physiological and pathophysiological settings are associated with such changes and to explore mechanisms by which exercise training increases the amount of Gs in the heart.
